Observe Medical
高管
查看带有其 7 名主要高管的组织结构图
Observe Medical 搜索最多的简介
- Jorgen Mann, Interim Chief Executive Officer and Chief Commercial ...
- Line Tønnessen, Board Member
- Terje Bakken, Chairman of the Board
高管在Observe Medical变化
- Per Arne Nygard, Chief Financial Officer, 已经离开公司 (新闻发布的2024三月22号).
- Johan Fagerli 曾任 Finance Manager, 现任 Interim Chief Financial Officer (新闻发布的2024三月22号).
创建提醒
跟踪 Observe Medical 的高管变动
生物技术
Navamedic 拥有 2,337 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Aadi Bioscience 刚刚宣布为 100 筹款数百万美元。 (公布2024十二月20号).
- OraSure Technologies has announced the acquisition of Sherlock Biosciences (公布2024十二月20号).
- SiteOne Therapeutics 刚刚宣布为 100 筹款数百万美元。 (公布2024十二月20号).
生物技术 行业的其他推荐联系人
消息
Observe Medical 的最新新闻稿
- OBSERVE MEDICAL ASA: Last day of the subscription period in the subsequent offering
- OBSERVE MEDICAL ASA: Preliminary results of the subsequent offering
- Observe Medical ASA: Final result of the subsequent offering and allocation of shares; Updated amendments of loans from Navamedic ASA to be implemented including partial conversion to shares
- OBSERVE MEDICAL ASA: Approval and publication of prospectus, listing of the tranche 2 private placement shares and launch of subsequent offering
- Observe Medical ASA: Notification of transaction by close associate to primary insider and disclosure of large shareholding
- Observe Medical ASA: Agreement reached with Convatec to defer payments by 12 months
- Observe Medical ASA: Mandatory notification of trades by primary insider
- OBSERVE MEDICAL ASA: Resolutions to increase the share capital in connection with subsequent offering and conditional loan conversion
- Observe Medical ASA: Amendments to loan agreements with Navamedic ASA
- Observe Medical – DOC (Declaration of Conformity) signed for UnoMeter[TM ]Safeti[TM] Plus and subscription form for equity investment received from industrial partner
- View more press releases Close
通过电子邮件
